Cargando…

Assessment of Reactivity to the Administration of the mRNA Vaccine after Six Months of Observation

Background: The fast spread of the SARS-CoV-2 virus accelerated efforts to create an effective vaccine, and a novel mRNA vaccine was the first to appear effective. Scientific evidence regarding mRNA vaccination is limited; therefore, understanding how the immune system responds to an mRNA vaccine is...

Descripción completa

Detalles Bibliográficos
Autores principales:	Slomka, Sebastian, Zieba, Patrycja, Rosiak, Oskar, Piekarska, Anna
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9965775/ https://www.ncbi.nlm.nih.gov/pubmed/36851244 http://dx.doi.org/10.3390/vaccines11020366

Ejemplares similares

Comparison of Post-Vaccination Response between mRNA and Vector Vaccines against SARS-CoV-2 in Terms of Humoral Response after Six Months of Observation
por: Slomka, Sebastian, et al.
Publicado: (2023)

Six-month longitudinal immune kinetics after mRNA-1273 vaccination: Correlation of peak antibody response with long-term, cross-reactive immunity
por: Choi, Min Joo, et al.
Publicado: (2023)

Humoral Immune Response in IBD Patients Three and Six Months after Vaccination with the SARS-CoV-2 mRNA Vaccines mRNA-1273 and BNT162b2
por: Vollenberg, Richard, et al.
Publicado: (2022)

Antibody responses elicited by mRNA vaccination in firefighters persist six months and correlate inversely with age and directly with BMI
por: Holtkamp, Caroline, et al.
Publicado: (2022)

Antibody Response Six Months after SARS-CoV-2 mRNA Vaccination in Patients with Inflammatory Bowel Disease
por: Frey, Sarah, et al.
Publicado: (2022)

Optimization of Lipid Nanoparticles for Intramuscular Administration of mRNA Vaccines
por: Hassett, Kimberly J., et al.
Publicado: (2019)

Six‐months immunogenicity of BNT162b2 mRNA vaccine in heart transplanted and ventricle assist device‐supported patients
por: Itzhaki Ben Zadok, Osnat, et al.
Publicado: (2022)

Six-month humoral response to mRNA SARS-CoV-2 vaccination in patients with multiple sclerosis treated with ocrelizumab and fingolimod
por: Capuano, Rocco, et al.
Publicado: (2022)

Six months SARS-CoV-2 serology in a cohort of mRNA vaccinated subjects over 90 years old
por: Tomaiuolo, Rossella, et al.
Publicado: (2022)

Durability of Antibody Response Six Months After Two-Dose SARS-CoV-2 mRNA Vaccination in Patients with Cirrhosis
por: Hughes, Robert M., et al.
Publicado: (2023)

Myasthenia Gravis Presenting after Administration of the mRNA-1273 Vaccine
por: Hoshina, Yoji, et al.
Publicado: (2022)

Varicella zoster virus reactivation and mRNA vaccines as a trigger
por: Lladó, Iñigo, et al.
Publicado: (2021)

Covid-19 mRNA Vaccines — Six of One, Half a Dozen of the Other
por: Rubin, Eric J., et al.
Publicado: (2021)

Evidence of SARS-CoV-2-Specific Memory B Cells Six Months After Vaccination With the BNT162b2 mRNA Vaccine
por: Ciabattini, Annalisa, et al.
Publicado: (2021)

Six-month antibody persistence after BNT162b2 mRNA COVID-19 vaccination in patients with chronic lymphocytic leukemia
por: Herishanu, Yair, et al.
Publicado: (2022)

Six-month humoral response to BNT162b2 mRNA COVID-19 vaccine in people with multiple sclerosis treated with natalizumab
por: Altieri, Manuela, et al.
Publicado: (2022)

Overview of Anti-SARS-CoV-2 Immune Response Six Months after BNT162b2 mRNA Vaccine
por: Gandolfo, Claudia, et al.
Publicado: (2022)

Humoral Response to mRNA-1273 SARS-CoV-2 Vaccine in Peritoneal Dialysis Patients: Is Boostering After Six Months Adequate?
por: Beilhack, Georg, et al.
Publicado: (2022)

Risk of strong antibody decline in dialysis and transplant patients after SARS-CoV-2mRNA vaccination: Six months data from the observational Dia-Vacc study
por: Stumpf, Julian, et al.
Publicado: (2022)

mRNA as a Therapeutics: Understanding mRNA Vaccines
por: Oğuz, Ferdi, et al.
Publicado: (2022)

mRNA Vaccine Platform: mRNA Production and Delivery
por: Litvinova, V. R., et al.
Publicado: (2023)

Case of reactive sacroiliitis possibly induced by an mRNA coronavirus disease vaccine
por: Roux, Nicolas, et al.
Publicado: (2022)

Effect of COVID-19 on Anti-S Antibody Response in Healthcare Workers Six Months Post-Vaccination
por: Flisiak, Robert, et al.
Publicado: (2021)

Assessment 2 months after the administration of a 3rd dose mRNA: a new variant-adapted vaccine is expected
por: Tré-Hardy, Marie, et al.
Publicado: (2022)

BNT162b2 mRNA Vaccine Interference with Co-Administration of Tdap Vaccine
por: Chilimuri, Sridhar, et al.
Publicado: (2021)

Reactivation of BCG vaccination scars after vaccination with mRNA-Covid-vaccines: two case reports
por: Mohamed, Libin, et al.
Publicado: (2021)

Vertigo and Severe Balance Instability as Symptoms of Lyme Disease—Literature Review and Case Report
por: Jozefowicz-Korczynska, Magdalena, et al.
Publicado: (2019)

Evaluation of mRNA-1273 Vaccine in Children 6 Months to 5 Years of Age
por: Anderson, Evan J., et al.
Publicado: (2022)

Dangers of mRNA vaccines
por: Ali, Tahoora, et al.
Publicado: (2021)

mRNA-Based Vaccines
por: Kowalzik, Frank, et al.
Publicado: (2021)

Advances in mRNA vaccines
por: Li, Mengyun, et al.
Publicado: (2022)

Six month immunogenicity of COVID-19 mRNA-BNT162b2 vaccine in actively treated cancer patients: updated results of the Vax-On study
por: Nelli, F., et al.
Publicado: (2022)

Letter to the editor: Six‐month antibody kinetics and durability in liver transplant recipients after two doses of SARS‐CoV‐2 mRNA vaccination
por: Chang, Amy, et al.
Publicado: (2022)

Transverse myelitis 48 hours after the administration of an mRNA COVID 19 vaccine
por: McLean, Patrick, et al.
Publicado: (2021)

The role of nanoparticle format and route of administration on self-amplifying mRNA vaccine potency
por: Anderluzzi, Giulia, et al.
Publicado: (2022)

Delayed cutaneous reactions after the administration of mRNA vaccines against COVID-19
por: Juárez Guerrero, Alba, et al.
Publicado: (2021)

Exacerbation of Lupus Erythematosus Panniculitis After Administration of COVID-19 mRNA Vaccine
por: Avcı, Ceylan, et al.
Publicado: (2022)

Relapsing TIPIC Syndrome after Administration of an mRNA-Based COVID-19 Vaccine
por: Sandu, Georgiana C., et al.
Publicado: (2023)

mRNA vaccines: the most recent clinical applications of synthetic mRNA
por: Kwon, Suji, et al.
Publicado: (2022)

Myocarditis following COVID‐19 mRNA (mRNA‐1273) vaccination
por: Chellapandian, Suresh Babu, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_ennf3vjgj60kttovr2vs9unq0p